Page last updated: 2024-08-26

bosentan anhydrous and Bowel Diseases, Inflammatory

bosentan anhydrous has been researched along with Bowel Diseases, Inflammatory in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anthoni, C; Krieglstein, CF; Laukötter, MG; Mennigen, RB; Rijcken, EJ; Schürmann, G; Senninger, N; Spiegel, HU	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Bowel Diseases, Inflammatory

Article	Year
Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease. International journal of colorectal disease, 2006, Volume: 21, Issue:5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bosentan; Cell Adhesion; Disease Models, Animal; Endothelin Receptor Antagonists; Female; Inflammatory Bowel Diseases; Leukocytes; Mice; Mice, Inbred BALB C; Severity of Illness Index; Sulfonamides	2006

Article

Year

Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease.

International journal of colorectal disease, 2006, Volume: 21, Issue:5

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bosentan; Cell Adhesion; Disease Models, Animal; Endothelin Receptor Antagonists; Female; Inflammatory Bowel Diseases; Leukocytes; Mice; Mice, Inbred BALB C; Severity of Illness Index; Sulfonamides

2006